We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

News   Sep 25, 2020 | Original story from University of New Hampshire

 
University of New Hampshire Awarded $1.8 M To Explore Drug Interactions and Targeted Drug Development

Credit: NikolayFrolochkin/Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Gut Bacteria May Be Responsible for Adverse Effect of Parkinson's Drug

News

Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson's disease.

READ MORE

A New Way To Personalize Prostate Cancer Treatment

News

A team of researchers has identified biomarkers that can predict if a prostate cancer patient has a high probability of developing metastasis.

READ MORE

New Test Can Target and Capture Most Lethal Cells in Fatal Brain Cancer

News

A laboratory test developed by a research team led by Johns Hopkins University bioengineers can accurately pinpoint, capture and analyze the deadliest cells in the most common and aggressive brain cancer in adults.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE